Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Iorio

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Plos One|May 7, 2013
Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical propertiesMichael P Menden, Francesco Iorio, Mathew Garnett, et al.
Plos One|October 10, 2015
A Semi-Supervised Approach for Refining Transcriptional Signatures of Drug Response and Repositioning PredictionsFrancesco Iorio, Roshan L Shrestha, Nicolas Levin, et al.
Scientific Reports|May 2, 2018
Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrichFrancesco Iorio, Luz Garcia-Alonso, Jonathan S Brammeld, et al.
Genome Biology|September 5, 2024
Author Correction: A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening dataAlessandro Vinceti, Rafaele M Iannuzzi, Isabella Boyle, et al.
Genome Biology|July 19, 2024
A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening dataAlessandro Vinceti, Raffaele M Iannuzzi, Isabella Boyle, et al.
Scientific Reports|November 24, 2016
Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapyTheo A Knijnenburg, Gunnar W Klau, Francesco Iorio, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|July 19, 2012
Cancer develops, progresses and responds to therapies through restricted perturbation of the protein-protein interaction networkJordi Serra-Musach, Helena Aguilar, Francesco Iorio, et al.
Cell Systems|May 22, 2020
CELLector: Genomics-Guided Selection of Cancer In Vitro ModelsHanna Najgebauer, Mi Yang, Hayley E Francies, et al.
The CRISPR Journal|January 2, 2024
Benchmark Software and Data for Evaluating CRISPR-Cas9 Experimental Pipelines Through the Assessment of a Calibration ScreenRaffaele M Iannuzzi, Ichcha Manipur, Clare Pacini, et al.
Genome Biology|May 1, 2013
Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitorsPedro Casado, Maria P Alcolea, Francesco Iorio, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Plos One|May 7, 2013
Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical propertiesMichael P Menden, Francesco Iorio, Mathew Garnett, et al.
Plos One|October 10, 2015
A Semi-Supervised Approach for Refining Transcriptional Signatures of Drug Response and Repositioning PredictionsFrancesco Iorio, Roshan L Shrestha, Nicolas Levin, et al.
Scientific Reports|May 2, 2018
Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrichFrancesco Iorio, Luz Garcia-Alonso, Jonathan S Brammeld, et al.
Genome Biology|September 5, 2024
Author Correction: A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening dataAlessandro Vinceti, Rafaele M Iannuzzi, Isabella Boyle, et al.
Genome Biology|July 19, 2024
A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening dataAlessandro Vinceti, Raffaele M Iannuzzi, Isabella Boyle, et al.
Scientific Reports|November 24, 2016
Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapyTheo A Knijnenburg, Gunnar W Klau, Francesco Iorio, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|July 19, 2012
Cancer develops, progresses and responds to therapies through restricted perturbation of the protein-protein interaction networkJordi Serra-Musach, Helena Aguilar, Francesco Iorio, et al.
Cell Systems|May 22, 2020
CELLector: Genomics-Guided Selection of Cancer In Vitro ModelsHanna Najgebauer, Mi Yang, Hayley E Francies, et al.
The CRISPR Journal|January 2, 2024
Benchmark Software and Data for Evaluating CRISPR-Cas9 Experimental Pipelines Through the Assessment of a Calibration ScreenRaffaele M Iannuzzi, Ichcha Manipur, Clare Pacini, et al.
Genome Biology|May 1, 2013
Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitorsPedro Casado, Maria P Alcolea, Francesco Iorio, et al.
Pageof 10